GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (SHSE:688185) » Definitions » Days Sales Outstanding

CanSino Biologics (SHSE:688185) Days Sales Outstanding : 491.86 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is CanSino Biologics Days Sales Outstanding?

CanSino Biologics's average Accounts Receivable for the three months ended in Mar. 2024 was ¥616.0 Mil. CanSino Biologics's Revenue for the three months ended in Mar. 2024 was ¥114.3 Mil. Hence, CanSino Biologics's Days Sales Outstanding for the three months ended in Mar. 2024 was 491.86.

The historical rank and industry rank for CanSino Biologics's Days Sales Outstanding or its related term are showing as below:

SHSE:688185' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.59   Med: 304   Max: 798.51
Current: 704.82

During the past 8 years, CanSino Biologics's highest Days Sales Outstanding was 798.51. The lowest was 7.59. And the median was 304.00.

SHSE:688185's Days Sales Outstanding is ranked worse than
98.89% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs SHSE:688185: 704.82

CanSino Biologics's Days Sales Outstanding declined from Mar. 2023 (776.34) to Mar. 2024 (491.86).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


CanSino Biologics Days Sales Outstanding Historical Data

The historical data trend for CanSino Biologics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Days Sales Outstanding Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial - 425.92 7.62 179.38 789.03

CanSino Biologics Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 776.34 - 451.05 347.09 491.86

Competitive Comparison of CanSino Biologics's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanSino Biologics's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's Days Sales Outstanding falls into.



CanSino Biologics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CanSino Biologics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (855.49 + 636.882) / 2 ) / 345.182*365
=746.186 / 345.182*365
=789.03

CanSino Biologics's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (636.882 + 595.13) / 2 ) / 114.282*365 / 4
=616.006 / 114.282*365 / 4
=491.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanSino Biologics  (SHSE:688185) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


CanSino Biologics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


CanSino Biologics (SHSE:688185) Business Description

Traded in Other Exchanges
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

CanSino Biologics (SHSE:688185) Headlines

No Headlines